Group Action Lawyers
Latest News & Updates

Tag: medicinal drugs

injection warning
June 29, 2018
A troubling testimony in the Gosport War Memorial Hospital deaths

A troubling testimony in the Gosport War Memorial Hospital deaths has been recounted in the recent independent inquiry that deemed some 450 deaths at the hospital were linked to an unsafe opioid-use policy.

Families who have been fighting for an inquiry for years have finally received the news that they say they knew all along: that their loved-ones died in the hospital prematurely.

At the centre of the Gosport War Memorial Hospital deaths scandal is Dr Jane Barton; the GP stationed there who claims that she was only ever doing the best for her patients. One particularly troubling testimony from 2001 that was recounted in the independent report paints a different story entirely.

Continue Reading…

anti-depressants prescriptions for children
April 27, 2018
Xarelto side-effects when mixed with other drugs

The issue of Xarelto side-effects when mixed with other drugs is currently being considered as part of the ongoing court action for negligence claims against the manufacturers of Xarelto who allegedly failed to warn users of dangerous side-effects related to use of the drug.

The blood-thinning, anti-stroke drug Xarelto – also sold under the name Rivaroxaban – has been linked to internal bleeding, and negligence claims against the manufacturers are over whether they knew of the risks of internal bleeding associated with the product but failed to warn anyone.

Our Group Action Lawyers have taken on cases to investigate claims here in the UK.
Continue Reading…

pregnancy epilepsy drug concerns
February 28, 2018
Birth defects reportedly caused by in-utero exposure to Epilepsy Drug

A drug that helps control epileptic seizures has been reportedly linked to birth defects and should not be used by pregnant women or women of child-bearing potential.

Depakote was created by French pharmaceutical drug company Sanofi back in 1967. The British equivalent, Epilim, has been available since 1973.

The drug has been used around the world and has gained regulatory approval for treatment of epilepsy, with variations of the drug introduced in 1995 for bipolar manic episodes, and in 1996 to prevent migraines. But, a generation later, it has been revealed the drug can cause severe birth defects at a significantly high percentage.
Continue Reading…